CRT - Scientific Advisory Board About Us Who We Are What We Do What We Offer CRT Inc.
CRT - Scientific Advisory Board Working with CRT Testimonials New Invention?
CRT - Scientific Advisory Board Working with CRT Technology Transfer Testimonials Services Financial Arrangements Development Funding CRT Development Laboratories Drug Discovery Biotherapeutic Development Senior Scientists Scientific Advisory Board Case Studies Pipeline Strategic Alliances Existing Partners CRT Scientific Advisory Board Prof Herbie Newell [ Biography ] Dr Barry Ross [ Biography ] Dr Karen Zinkewich...
Millennium | Media | Press Releases | 2003 | 2003-06-02 2003 2002 Millennium Announces Preliminary Phase I and Phase II Findings of VELCADE™ (bortezomib) for Injection in Studies of Non-Hodgkin's Lymphoma and Solid Tumors – Evidence of anti-tumor activity reported with VELCADE as a single agent and in combination with other therapies – Chicago, Ill., June 2, 2003 - Millennium Pharmaceuticals, Inc.
Retinoblastoma: Childhood Cancers: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
Ovarian Cancer: Cancers of the Female Reproductive System: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
GPC-Biotech /* @import url(/css/styles.css);*/ @import url(/css/custom.css); @import url(/css/download.css); @import url(/css/styles.css); @import url(/css/custom.css); /* @import url(/css/styles_print.css);*/ Home Deutsch About the Company Anticancer Programs Technologies Investor Relations News &-Media Careers Calendar Contact/- Imprint Sitemap Search Glossary Forward Look-ing Statements...
author: Form+Fakten, Maximilian Vollendorf
Genentech: Investor Relations - Financials - 2001 Third Quarter Report Home Contact Us Site Index Search [ Investors -- Financials -- Quarterly Reports -- 2001 Third Quarter Report ] Investors Home Calendar of Events Contacts Corporate Governance E-Delivery of Annual Report E-Mail Alerts Fact Sheet FAQs Financials Annual Reports Quarterly Reports--- Earnings Releases GAAP vs Non-GAAP Reconciliation Other Income, Net Historical Product Sales 11-Year...
Carboplatin - [Medication] - Quest Diagnostics Patient Health Library Carboplatin Examples Brand Name Chemical Name Paraplatin carboplatin How It Works Carboplatin is an intravenous (IV) medication usually given in a dose based on body surface area.Carboplatin - [Medication] - Quest Diagnostics Patient...
BioPortfolio Limited Datamonitor Oncology Reports [ Home ] - [ Up ] - [ Catalog ] - [ Info ] - [ Search ] - [ View Basket ] - [ Checkout ] - [ Send email ] - BioPortfolio accept VISA, MASTERCARD and AMEX Bioportfolio - - Datamonitor Oncology Reports Casodex 150mg - What now for AstraZeneca’s prostate cancer product?
Cancer the generic impact - - - - BioNews BioWeb Companies Products BioReports - - - - - Cancer: the generic impact The cancer market is set for a boom in low cost drugs, as a significant number of high value cancer drugs are set to lose patent protection over the next decade, triggering a dramatic influx of cheaper generic equivalents.
Lung Cancer: Eli Lilly’s Affinitac to challenge the cytotoxics - - - - BioNews BioWeb Companies Products BioReports - - - - - Lung Cancer: Eli Lilly’s Affinitac to challenge the cytotoxics Lung cancer is one of the most prevalent forms of cancer to afflict both men and women, accounting for nearly 15% of all cancer cases.Paraplatin (...
Lung Cancer: Eli Lilly’s Affinitac to challenge the cytotoxics - - - - BioNews BioWeb Companies Products BioReports - - - - - Lung Cancer: Eli Lilly’s Affinitac to challenge the cytotoxics Lung cancer is one of the most prevalent forms of cancer to afflict both men and women, accounting for nearly 15% of all cancer cases.Paraplatin (...
BioPortfolio Limited Commercial Insight: Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market TABLE OF CONTENTS About Datamonitor Healthcare 2 CHAPTER 1 EXECUTIVE SUMMARY 3 CHAPTER 2 MARKET DEFINITION AND OVERVIEW 12 Scope 12 Market definition for this report 12 Cytotoxics 13 L1A – Alkylating agents 13 L1B – Antimetabolites 13 L1C – Vinca alkaloids and other plant products...
Teva Pharmaceutical Industries - News and PR - - Search Tevapharm: - - Press Release Teva Announces Tentative Approval of Carboplatin Injection Jerusalem, Israel, January 15, 2003 - Teva Pharmaceutical Industries Ltd.Carboplatin Injection, 50 mg, 150 mg, and 450 mg.Carboplatin Injection is the generic equivalent...
Teva Pharmaceutical Industries - News and PR - - Search Tevapharm: - - Press Release Teva Announces Settlement Of Carboplatin Litigation With Bristol-Myers Squibb; Will Market And Sell Product In The U.S.carboplatin injection, the generic...
Teva Pharmaceutical Industries - News and PR - - Search Tevapharm: - - Press Release Teva Commences Shipments Of Carboplatin Jerusalem, Israel, June 24, 2004 - Teva Pharmaceutical Industries Ltd.carboplatin injection (50 mg, 150 mg, 450 mg) and carboplatin aqueous solution injection (50 mg/5 ml, 150 mg/15 ml, and 450 mg/45 ml).carboplatin injection and...
Microsoft Word - NewYork_2683824_9.DOC page 19
Specificity Table TOX.xls Tested (ng/ ml) Paral Paraldehyde Sedative 1,000,000 Paramorphine Thebaine Opiate 100,000 OPI 24,000 para- Nitrophenol para- Nitrophenol Dye 100,000 Paraplatin Carboplatin Antineoplastic 100,000 Paredrine Amphetamine analog( Hydroxyamphetamine, p-) Amphetamine analog 200,000 AMP 20,000 Parlodel Bromoergocryptine, 2- a- Antiparkinsonian 100,000 Parnate Tranylcypromine...
author: Biosite Incorporated
Specificity Table TOX.xls page 20
author: Biosite Incorporated
Prescription and Over-the-Counter Drug Product List: 1/2004 ADULT >A> + AAIPHARMA LLC 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL ;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL; 40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/V IAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL N21625 001 JAN 30, 2004 JAN NEWA BETAMETHASONE DIPROPIONATE CREAM, AUGMENTED; TOPICAL BETAMETHASONE DIPROPIONATE >A> AB ATRIX EQ 0.05% BASE N76603 001 JAN 23, 2004 JAN NEWA BUPROPION HYDROCHLORIDE TABLET, EXTENDED...
Paragraph IV Patent Certifications - DRUG NAME DOSAGE FORM STRENGTH RLD Acetaminophen Extended-release Tablets 650 mg Tylenol Acetaminophen/ Aspirin/ Caffeine Tablets 250 mg/250 mg/ 65 mg Excedrin (migraine) Acetaminophen and Tramadol Hydrochloride Tablets 325 mg/ 37.5 mg Ultracet Acyclovir Sodium1 Injection 50 mg/mL, 10 mL and 20 mL vials Zovirax Albuterol Sulfate Oral Syrup 2 mg(base)/ 5 mL Ventolin Albuterol...
http://www.fda.gov/cder/orange/appendix_a.txt SODIUM, AMINOSALICYLATE SODIUM PACERONE, AMIODARONE HYDROCHLORIDE PACLITAXEL, PACLITAXEL PAGITANE, CYCRIMINE HYDROCHLORIDE PAMELOR, NORTRIPTYLINE HYDROCHLORIDE PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM PAMINE FORTE, METHSCOPOLAMINE BROMIDE PAMINE, METHSCOPOLAMINE BROMIDE PANCURONIUM BROMIDE, PANCURONIUM BROMIDE PANCURONIUM, PANCURONIUM BROMIDE PANDEL, HYDROCORTISONE PROBUTATE...
NDA Approvals for Calendar Year 2003 NDA APPROVALS FOR CALENDAR YEAR 2003 Updated through December 31, 2003 NDA NUMBER DRUG NAME GENERIC NAME APPLICANT/ SPONSOR CHEMICAL TYPE THERAPEUTIC CLASS APPROVAL DATE - 21434 Xanax XR Alprazolam Pharmacia and Upjohn FR 3 S 17-Jan-03 21305 Sodium Iodide I-131 Sodium Iodide I-131 DraxImage 3,5 S 24-Jan-03 20414 Pyridostigmine Bromide Pyridostigmine Bromide US Army 3 P 05-Feb-03...
author: Susan Daugherty
Microsoft Word - Approval.doc 1 of 24 Rx only PARAPLATIN (carboplatin aqueous solution) INJECTION WARNING PARAPLATIN (carboplatin aqueous solution) INJECTION should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agentsPARAPLATIN ® (carboplatin aqueous solution) INJECTION is supplied as a...
author: COTTRELLC
